Statement Of Cash Flows [Abstract]

Mithra Pharmaceuticals S.A. - Filing #3183075

Concept As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operating activities
56 819 EUR
76 788 EUR
Cash flows from (used in) investing activities [abstract]
Proceeds from sales of property, plant and equipment, classified as investing activities
169,000 EUR
- EUR
Purchase of property, plant and equipment, classified as investing activities
6 356 EUR
11 483 EUR
Purchase of intangible assets, classified as investing activities
19 302 EUR
9 699 EUR
Cash flows from (used in) investing activities
25 490 EUR
54 682 EUR
Cash flows from (used in) financing activities [abstract]
Payments of lease liabilities, classified as financing activities
6 663 EUR
7 193 EUR
Proceeds from government grants, classified as financing activities
154,000 EUR
41,000 EUR
Interest paid, classified as financing activities
9 862 EUR
9 364 EUR
Cash flows from (used in) financing activities
77 869 EUR
25 646 EUR
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents
147,000 EUR
21,000 EUR
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes
4 440 EUR
105 824 EUR
Cash and cash equivalents
28,285,000 EUR
32,872,000 EUR
138,675,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.